Interview: Lord O’Shaughnessy – Parliamentary Under Secretary of State for Health, Department of Health and Social Care, UK
Interview: Tatsuya Kondo – Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
"Shenzhen has a diverse range of companies working across antibiotics, oncology, Chinese medicine, API and peptide manufacturing, and both small- and large-molecule drug development"
PharmaBoardroom Releases ‘Disruptive Trends in Pharma Regulation’ June 2018 Special Report
PharmaBoardroom today releases its new 36-page special report, Disruptive Trends in Pharma Regulation While drug developers, healthcare practitioners and patients all rejoice at the advent of a golden age of scientific advancement in medicine – symbolized by recent radical breakthroughs …